Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis

Published:2019-06-10 Issue:9 Volume:24 Page:1151-1160
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

XiaoHong Chen,Bo Shen,FangFang Xiang,Man Guo,JianZhou Zou,ZhongHua Liu,WenLv Lv,XueSen Cao,XiaoQiang Ding,Boheng Zhang

Funder

Shanghai Clinical Medical Center for Kidney Disease Project support by Shanghai Municipal Health Commission

Shanghai Municipal Hospital Frontier Technology Project supported by Shanghai ShenKang Hospital Development Center

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01455-5.pdf

Reference55 articles.

1. Chien CC, Han MM, Chiu YH et al (2017) Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer 8(1):9–18. https://doi.org/10.7150/jca.16550

2. Cheung CY, Chan GC, Chan SK et al (2016) Cancer incidence and mortality in chronic dialysis population: a multicenter cohort study. Am J Nephrol 43(3):153–159. https://doi.org/10.1159/000445362

3. Butler AM, Olshan AF, Kshirsagar AV et al (2015) Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996–2009. Am J Kidney Dis 65(5):763–772. https://doi.org/10.1053/j.ajkd.2014.12.013

4. Maisonneuve P, Agodoa L, Gellert R et al (1999) Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet (London, England) 354(9173):93–99

5. Vamvakas S, Bahner U, Heidland A (1998) Cancer in end-stage renal disease: potential factors involved—editorial. Am J Nephrol 18(2):89–95. https://doi.org/10.1159/000013314

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever;Scientific Reports;2023-11-01

2. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever;2022-12-22

3. Renal cell carcinoma in native nephrectomy specimens of autosomal dominant polycystic kidney disease (ADPKD) patients with end-stage renal disease: Findings from an Australian transplant center;Journal of Clinical Urology;2021-05-24

4. Differences between exhausted CD8+ T cells in hepatocellular carcinoma patients with and without uremia;Canadian Journal of Physiology and Pharmacology;2021-04

5. Successful treatment of a hemodialysis patient with advanced renal cell carcinoma with nivolumab plus ipilimumab immunotherapy： A case report;Nihon Toseki Igakkai Zasshi;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3